Skip to main content

Animations

MJFF Publications

5151 - 5175 of 9145 Results
Title
Year
  • Year
  • 2022
  • 2020
  • 2023
  • 2017
  • 2025
  • 2024
  • 2025
  • 2025
  • 2025
  • 2006
  • 2005
  • 2017
  • 2010
  • 2010
  • 2025
  • 2016
  • 2019
  • 2020
  • 2018
  • 2020
  • 2022
  • 2020
  • 2016
  • 2026
  • 2020
  • Summary Details
    OPEN
    Title: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-223190
    Citation Count: 15
  • Baseline-dependency: How genotype and signaled delays influence amphetamine's effects on delay discounting
    2020
    Summary Details
    RESTRICTED
    Title: Baseline-dependency: How genotype and signaled delays influence amphetamine's effects on delay discounting
    Journal Name: Pharmacology Biochemistry and Behavior
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pbb.2020.173070
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s disease
    Journal Name: Journal of Biopharmaceutical Statistics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/10543406.2023.2170400
    Citation Count: 8
  • Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient
    2017
    Summary Details
    RESTRICTED
    Title: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient
    Journal Name: Clinical Neuropharmacology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230
    Citation Count: 7
  • Summary Details
    OPEN
    Title: TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01180-z
    Citation Count: 4
  • Summary Details
    OPEN
    Title: A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related Disorders
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-230257
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The patient-specific mouse model with Foxg1 frameshift mutation provides insights into the pathophysiology of FOXG1 syndrome
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41467-025-59838-4
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Longitudinal characterization of clinical, developmental, and behavioral phenotypes in 101 children and adults with FOXG1 syndrome
    Journal Name: Journal of Neurodevelopmental Disorders
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1186/s11689-025-09653-1
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Design considerations for C9orf72 disease prevention trials
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf290
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(06)70579-8
    Citation Count: 82
  • Oxidative Damage in Parkinson's Disease
    2005
    Summary Details
    RESTRICTED
    Title: Oxidative Damage in Parkinson's Disease
    Journal Name: Antioxidants & Redox Signaling
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1089/ars.2005.7.627
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Increasing Efficiency of Recruitment in Early Parkinson’s Disease Trials: A Case Study Examination of the STEADY-PD III Trial
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-171199
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevin
    Journal Name: NeuroReport
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3b
    Citation Count: 15
  • Biomarkers in Parkinson‘s Disease: A Funder‘s Perspective
    2010
    Summary Details
    RESTRICTED
    Title: Biomarkers in Parkinson‘s Disease: A Funder‘s Perspective
    Journal Name: Biomarkers in Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/bmm.10.89
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Review of the Effects of Lifestyle Modification on Parkinson’s Disease
    Journal Name: American Journal of Lifestyle Medicine
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1177/15598276251384591
    Citation Count: 2
  • Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease
    2016
    Summary Details
    OPEN
    Title: Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-161031
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confounding
    Journal Name: Annals of Epidemiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.annepidem.2019.04.010
    Citation Count: 13
  • Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
    2020
    Summary Details
    OPEN
    Title: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/58956
    Citation Count: 12
  • Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review
    2018
    Summary Details
    RESTRICTED
    Title: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review
    Journal Name: Clinical Neuropharmacology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296
    Citation Count: 12
  • Summary Details
    OPEN
    Title: The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells9081878
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Promoting Physical Activity Among Immigrant Asian Americans: Results from Four Community Health Worker Studies
    Journal Name: Journal of Immigrant and Minority Health
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s10903-022-01411-y
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Forecasts for the Attainment of Major Research Milestones in Parkinson’s Disease
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-201933
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Parkinson’S Disease is Ready for Precision Medicine
    Journal Name: Personalized Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2217/pme-2016-0052
    Citation Count: 7
  • How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early‐Stage Neuronal Alpha‐Synuclein Disease
    2026
    Summary Details
    RESTRICTED
    Title: How PPMI Enabled the First Interventional Platform Trial to Test Therapies in Participants With Early‐Stage Neuronal Alpha‐Synuclein Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.78250
    Citation Count: 0
  • PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)
    2020
    Summary Details
    RESTRICTED
    Title: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490
    Citation Count: 7
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.